- Report
- March 2025
- 400 Pages
Global
From €3987EUR$4,490USD£3,459GBP
- Report
- February 2025
- 200 Pages
Global
From €3987EUR$4,490USD£3,459GBP
- Report
- April 2025
- 175 Pages
Global
From €3987EUR$4,490USD£3,459GBP
- Report
- April 2025
- 175 Pages
Global
From €3987EUR$4,490USD£3,459GBP
- Report
- April 2025
- 175 Pages
Global
From €3987EUR$4,490USD£3,459GBP
- Report
- April 2025
- 250 Pages
Global
From €3987EUR$4,490USD£3,459GBP
- Report
- March 2025
- 175 Pages
Global
From €3987EUR$4,490USD£3,459GBP
- Report
- March 2025
- 250 Pages
Global
From €3987EUR$4,490USD£3,459GBP
- Report
- February 2025
- 200 Pages
Global
From €3987EUR$4,490USD£3,459GBP
- Report
- February 2025
- 200 Pages
Global
From €3987EUR$4,490USD£3,459GBP
- Report
- January 2026
- 375 Pages
Global
From €5195EUR$5,850USD£4,507GBP
- Report
- January 2026
- 201 Pages
Global
From €5195EUR$5,850USD£4,507GBP
- Report
- January 2026
- 282 Pages
Global
From €5195EUR$5,850USD£4,507GBP
- Report
- January 2026
- 282 Pages
Global
From €5195EUR$5,850USD£4,507GBP
- Report
- January 2026
- 272 Pages
Global
From €5195EUR$5,850USD£4,507GBP
- Report
- January 2026
- 131 Pages
Global
From €5195EUR$5,850USD£4,507GBP
- Report
- January 2026
- 291 Pages
Global
From €5195EUR$5,850USD£4,507GBP
- Report
- January 2026
- 456 Pages
Global
From €5195EUR$5,850USD£4,507GBP
- Report
- January 2026
- 368 Pages
Global
From €5195EUR$5,850USD£4,507GBP
- Report
- January 2026
- 192 Pages
Global
From €5195EUR$5,850USD£4,507GBP

The Continuous Glucose Monitoring (CGM) market is a subset of the larger glucose testing market. CGM is a technology that allows for the continuous monitoring of glucose levels in the body. It is typically used by people with diabetes to help them better manage their condition. CGM systems consist of a sensor, transmitter, and receiver. The sensor is inserted under the skin and measures glucose levels in the interstitial fluid. The transmitter sends the data to the receiver, which displays the glucose levels. CGM systems can provide real-time data and alert users when their glucose levels are too high or too low.
Some companies in the CGM market include Dexcom, Abbott, Medtronic, and Senseonics. Show Less Read more